Skip to main content
. 2018 Aug 31;5(5):846–857. doi: 10.1002/ehf2.12298

Figure 3.

Figure 3

Expression of anaphylatoxin receptor C3aR is enhanced in patients with positive expression of established inflammatory markers in endomyocardial biopsy. C3aR‐positive cells were quantified by investigators blinded to the patient characteristics. Samples were categorized into two groups according to the number of cells positive for the analysed markers. Score 1 = one or more than one cells positive for the marker were counted; Score 0 = no cell positive for the marker. *P < 0.05. (A) 30/64 (46.9%) patients with positive MHCII expression showed positive C3aR expression (Score 1), which was higher for trend compared with 11/38 (28.9%) of MHCII‐negative patients, P = 0.076. (B) 29/62 (46.8%) patients with positive CD68 expression showed positive C3aR expression (Score 1), which was higher for trend compared with 12/40 (30.0%) CD68‐negative patients, P = 0.093.